Journal article · 2006

A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II

Xaver Schiel, Hartmut Link, Georg Maschmeyer, Bertram Glaß, Oliver A. Cornely, Dieter Buchheidt, Martin Wilhelm, Gerda Silling, Manfred Helmerking, Wolfgang Hiddemann, Helmut Ostermann, Marcus Hentrich and 1 more

Infection, 34(3), 118–126 · Published 1 June 2006 · DOI 10.1007/s15010-006-5113-9

View at the publisherCite this paper

In brief

“A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II” is a 2006 journal article by Xaver Schiel and 12 co-authors, published in Infection. OpenAlex counts 46 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
46
Most cited in
2012 (8)
Field-weighted impact
1.68
References
26
Authors
13

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Schiel, X., Link, H., Maschmeyer, G., Glaß, B., Cornely, O. A., Buchheidt, D., Wilhelm, M., Silling, G., Helmerking, M., Hiddemann, W., Ostermann, H., Hentrich, M., & for the Study Group of the Paul Ehrlich Society. (2006). A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II. Infection, 34(3), 118–126. https://doi.org/10.1007/s15010-006-5113-9

MLA 9

Schiel, Xaver, et al. “A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.” Infection, vol. 34, no. 3, 2006, pp. 118–126. https://doi.org/10.1007/s15010-006-5113-9.

Chicago

Schiel, Xaver, Hartmut Link, Georg Maschmeyer, Bertram Glaß, Oliver A. Cornely, Dieter Buchheidt, Martin Wilhelm, et al. 2006. “A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.” Infection 34 (3): 118–126. https://doi.org/10.1007/s15010-006-5113-9.

Harvard

Schiel, X. et al. (2006) ‘A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II’, Infection, 34(3), pp. 118–126. doi:10.1007/s15010-006-5113-9.

IEEE

X. Schiel et al., “A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II,” Infection, vol. 34, no. 3, pp. 118–126, 2006, doi: 10.1007/s15010-006-5113-9.

BibTeX

@article{schiel2006prospective,
  title     = {{A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II}},
  author    = {Schiel, Xaver and Link, Hartmut and Maschmeyer, Georg and Glaß, Bertram and Cornely, Oliver A. and Buchheidt, Dieter and Wilhelm, Martin and Silling, Gerda and Helmerking, Manfred and Hiddemann, Wolfgang and Ostermann, Helmut and Hentrich, Marcus and for the Study Group of the Paul Ehrlich Society},
  journal   = {Infection},
  year      = {2006},
  volume    = {34},
  number    = {3},
  pages     = {118--126},
  doi       = {10.1007/s15010-006-5113-9},
  url       = {https://doi.org/10.1007/s15010-006-5113-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201288
201322
201455
201522
201644
201755
202211
202333
202511

Its field-weighted citation impact is 1.68: it has been cited 1.68 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • febrile neutropenia
  • cancer patients
  • empirical antifungal therapy
  • amphotericin B deoxycholate
  • 5-fluorocytosine
  • fluconazole
  • piperacillin
  • aminoglycosides

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Schiel, X., Link, H., Maschmeyer, G., Glaß, B., Cornely, O. A., Buchheidt, D., Wilhelm, M., Silling, G., Helmerking, M., Hiddemann, W., Ostermann, H., Hentrich, M., & for the Study Group of the Paul Ehrlich Society. (2006). A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II. Infection, 34(3), 118–126. https://doi.org/10.1007/s15010-006-5113-9

How many times has this paper been cited?

46 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Xaver Schiel, Hartmut Link, Georg Maschmeyer, Bertram Glaß, Oliver A. Cornely, Dieter Buchheidt, Martin Wilhelm, Gerda Silling, Manfred Helmerking, Wolfgang Hiddemann, Helmut Ostermann, Marcus Hentrich and 1 more.

What is the DOI of this paper?

10.1007/s15010-006-5113-9, permanently at https://doi.org/10.1007/s15010-006-5113-9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.